3 ms·
This points to the real problem and also where the responsibility and interest ought to be to fix it. There’s no replication crisis for academics because they
by bee_rider 3y ago
This points to the real problem and also where the responsibility and interest ought to be to fix it.
There’s no replication crisis for academics because they have a meatspace social network of academics; they go to conferences together and know each other. You can just ignore a paper if you know the author is an idiot.
If medical studies are faked, is it a problem? Presumable regulatory agencies are using these studies or something, right? Looks like the FDA and NSF need to fund some more replication studies.
- jonlucc 3y agoAt least in pre-clinical research, there’s also a mechanism by which regulatory agencies can sometimes force industry to pay for replication studies. It’s a little complicated, because sometimes there aren’t many groups who can reliably do the study, and clinical trials are so expensive and time-consuming to run, it would be difficult to do at that scale. Rodent studies are generally under $1M and monkey studies are generally under $5M (up a lot recently). Clinical trials are in the hundreds of millions of dollars and take years to run.